Study of serum markers of bone mineral metabolism in patients with type 2 diabetes mellitus

Background: Limited published data are available regarding markers of bone mineral metabolism among patients with type 2 diabetes mellitus (T2DM). Methods: In this cross-sectional study conducted in 100 subjects during the period March 2021 to July 2022 we studied the markers of bone mineral metabol...

Full description

Saved in:
Bibliographic Details
Main Authors: V. Manolasya, Madhavi Gottam Bindhu, D. T. Katyarmal, Alok Sachan, M. M. Suchitra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of Clinical and Scientific Research
Subjects:
Online Access:https://journals.lww.com/10.4103/jcsr.jcsr_40_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849420807688683520
author V. Manolasya
Madhavi Gottam Bindhu
D. T. Katyarmal
Alok Sachan
M. M. Suchitra
author_facet V. Manolasya
Madhavi Gottam Bindhu
D. T. Katyarmal
Alok Sachan
M. M. Suchitra
author_sort V. Manolasya
collection DOAJ
description Background: Limited published data are available regarding markers of bone mineral metabolism among patients with type 2 diabetes mellitus (T2DM). Methods: In this cross-sectional study conducted in 100 subjects during the period March 2021 to July 2022 we studied the markers of bone mineral metabolism, namely, serum magnesium, calcium, inorganic phosphate and alkaline phosphatase in patients with T2DM (n = 50) and healthy controls (n = 50). Results: Both cases and controls were comparable in terms of age (P = 0.136) and gender (P = 0.68). Serum magnesium (mg/dL) (1.8 ± 0.3 Vs 2.1 ± 0.2; P < 0.001), and calcium (mg/dL) (8.4 ± 0.9 Vs 8.9 ± 0.7; P < 0.001) were significantly lower in cases compared with controls. Serum alkaline phosphatase (ALP) (IU/L) [105 (67.2-136.5) Vs 74 (54.8-108.5) was higher in cases compared to controls. Serum inorganic phosphate level (P = 0.093) and corrected calcium (P = 0.074) were within the normal range among cases and controls. Forty two out of 50 cases had poorly controlled T2DM [glycosylated haemoglobin (HbA1c) >7.0%]. Cases with poor glycaemic control had significantly lower serum magnesium levels compared with controlled diabetes (mg/dL) (1.7 ± 0.3 Vs 2.1 ± 0.2; P < 0.001). Serum magnesium levels were significantly lower in cases with macrovascular or microvascular complications compared with those without complications (1.760 ± 0.3 Vs 2 ± 0.2; P = 0.04). Conclusions: Cases had significantly lower serum magnesium, an important factor regulating parathormone secretion and action, compared to controls. Cases had significantly higher serum ALP level compared to controls, indicating the increased bone turnover, among patients with T2DM when compared to healthy individuals.
format Article
id doaj-art-82c5ba9a93f74b6aa79bd4be7519de2d
institution Kabale University
issn 2277-5706
2277-8357
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Clinical and Scientific Research
spelling doaj-art-82c5ba9a93f74b6aa79bd4be7519de2d2025-08-20T03:31:38ZengWolters Kluwer Medknow PublicationsJournal of Clinical and Scientific Research2277-57062277-83572025-01-01141394410.4103/jcsr.jcsr_40_23Study of serum markers of bone mineral metabolism in patients with type 2 diabetes mellitusV. ManolasyaMadhavi Gottam BindhuD. T. KatyarmalAlok SachanM. M. SuchitraBackground: Limited published data are available regarding markers of bone mineral metabolism among patients with type 2 diabetes mellitus (T2DM). Methods: In this cross-sectional study conducted in 100 subjects during the period March 2021 to July 2022 we studied the markers of bone mineral metabolism, namely, serum magnesium, calcium, inorganic phosphate and alkaline phosphatase in patients with T2DM (n = 50) and healthy controls (n = 50). Results: Both cases and controls were comparable in terms of age (P = 0.136) and gender (P = 0.68). Serum magnesium (mg/dL) (1.8 ± 0.3 Vs 2.1 ± 0.2; P < 0.001), and calcium (mg/dL) (8.4 ± 0.9 Vs 8.9 ± 0.7; P < 0.001) were significantly lower in cases compared with controls. Serum alkaline phosphatase (ALP) (IU/L) [105 (67.2-136.5) Vs 74 (54.8-108.5) was higher in cases compared to controls. Serum inorganic phosphate level (P = 0.093) and corrected calcium (P = 0.074) were within the normal range among cases and controls. Forty two out of 50 cases had poorly controlled T2DM [glycosylated haemoglobin (HbA1c) >7.0%]. Cases with poor glycaemic control had significantly lower serum magnesium levels compared with controlled diabetes (mg/dL) (1.7 ± 0.3 Vs 2.1 ± 0.2; P < 0.001). Serum magnesium levels were significantly lower in cases with macrovascular or microvascular complications compared with those without complications (1.760 ± 0.3 Vs 2 ± 0.2; P = 0.04). Conclusions: Cases had significantly lower serum magnesium, an important factor regulating parathormone secretion and action, compared to controls. Cases had significantly higher serum ALP level compared to controls, indicating the increased bone turnover, among patients with T2DM when compared to healthy individuals.https://journals.lww.com/10.4103/jcsr.jcsr_40_23calciumdiabetes mellitusinorganic phosphate and alkaline phosphatasemagnesium
spellingShingle V. Manolasya
Madhavi Gottam Bindhu
D. T. Katyarmal
Alok Sachan
M. M. Suchitra
Study of serum markers of bone mineral metabolism in patients with type 2 diabetes mellitus
Journal of Clinical and Scientific Research
calcium
diabetes mellitus
inorganic phosphate and alkaline phosphatase
magnesium
title Study of serum markers of bone mineral metabolism in patients with type 2 diabetes mellitus
title_full Study of serum markers of bone mineral metabolism in patients with type 2 diabetes mellitus
title_fullStr Study of serum markers of bone mineral metabolism in patients with type 2 diabetes mellitus
title_full_unstemmed Study of serum markers of bone mineral metabolism in patients with type 2 diabetes mellitus
title_short Study of serum markers of bone mineral metabolism in patients with type 2 diabetes mellitus
title_sort study of serum markers of bone mineral metabolism in patients with type 2 diabetes mellitus
topic calcium
diabetes mellitus
inorganic phosphate and alkaline phosphatase
magnesium
url https://journals.lww.com/10.4103/jcsr.jcsr_40_23
work_keys_str_mv AT vmanolasya studyofserummarkersofbonemineralmetabolisminpatientswithtype2diabetesmellitus
AT madhavigottambindhu studyofserummarkersofbonemineralmetabolisminpatientswithtype2diabetesmellitus
AT dtkatyarmal studyofserummarkersofbonemineralmetabolisminpatientswithtype2diabetesmellitus
AT aloksachan studyofserummarkersofbonemineralmetabolisminpatientswithtype2diabetesmellitus
AT mmsuchitra studyofserummarkersofbonemineralmetabolisminpatientswithtype2diabetesmellitus